- Home
- AUDC vs ALMS Comparison
AUDC vs ALMS Comparison
Compare AUDC & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- ALMS
- Stock Information
- Founded
- AUDC 1992
- ALMS 2021
- Country
- AUDC Israel
- ALMS United States
- Employees
- AUDC N/A
- ALMS N/A
- Industry
- AUDC Telecommunications Equipment
- ALMS
- Sector
- AUDC Utilities
- ALMS
- Exchange
- AUDC Nasdaq
- ALMS NYSE
- Market Cap
- AUDC 299.7M
- ALMS 260.6M
- IPO Year
- AUDC 1999
- ALMS 2024
- Fundamental
- Price
- AUDC $9.42
- ALMS $5.82
- Analyst Decision
- AUDC Buy
- ALMS Strong Buy
- Analyst Count
- AUDC 2
- ALMS 7
- Target Price
- AUDC $11.25
- ALMS $28.17
- AVG Volume (30 Days)
- AUDC 72.0K
- ALMS 1.2M
- Earning Date
- AUDC 05-06-2025
- ALMS 05-15-2025
- Dividend Yield
- AUDC 1.91%
- ALMS N/A
- EPS Growth
- AUDC 78.82
- ALMS N/A
- EPS
- AUDC 0.50
- ALMS N/A
- Revenue
- AUDC $242,176,000.00
- ALMS N/A
- Revenue This Year
- AUDC $5.11
- ALMS N/A
- Revenue Next Year
- AUDC $3.79
- ALMS N/A
- P/E Ratio
- AUDC $19.10
- ALMS N/A
- Revenue Growth
- AUDC N/A
- ALMS N/A
- 52 Week Low
- AUDC $7.70
- ALMS $3.18
- 52 Week High
- AUDC $13.11
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- AUDC 27.46
- ALMS N/A
- Support Level
- AUDC $9.85
- ALMS N/A
- Resistance Level
- AUDC $10.13
- ALMS N/A
- Average True Range (ATR)
- AUDC 0.27
- ALMS 0.00
- MACD
- AUDC -0.06
- ALMS 0.00
- Stochastic Oscillator
- AUDC 12.41
- ALMS 0.00
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.